Published in Surgery on May 01, 2007
Impact of surgery on quality of life in patients with hepatocellular carcinoma. World J Surg (2014) 2.06
Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. World J Surg (2011) 1.29
Nomogram predicting long-term survival after the diagnosis of intrahepatic recurrence of hepatocellular carcinoma following an initial liver resection. Int J Clin Oncol (2017) 1.14
Repeat hepatectomy for recurrent hepatocellular carcinoma: a local experience and a systematic review. World J Surg Oncol (2010) 1.12
Hepatocellular carcinoma: current management and future development-improved outcomes with surgical resection. Int J Hepatol (2011) 1.06
Laparoscopic liver resection in patients with a history of upper abdominal surgery. World J Surg (2011) 0.82
Pure laparoscopic hepatectomy as repeat surgery and repeat hepatectomy. World J Gastroenterol (2015) 0.81
Repeat treatment for recurrent hepatocellular carcinoma: is it validated? Langenbecks Arch Surg (2011) 0.81
Safety of hepatectomy for elderly patients with hepatocellular carcinoma. World J Gastroenterol (2014) 0.79
Oncolytic adenovirus SG600-IL24 selectively kills hepatocellular carcinoma cell lines. World J Gastroenterol (2010) 0.79
Role of hepatectomy for recurrent or initially unresectable hepatocellular carcinoma. World J Hepatol (2014) 0.79
Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma. World J Surg (2017) 0.78
Prognostic impact of treatment modalities on patients with single nodular recurrence of hepatocellular carcinoma. Surg Today (2009) 0.76
Peritoneal recurrence of initially controlled hepatocellular carcinoma after living donor liver transplantation. Case Rep Gastroenterol (2015) 0.75
Radiofrequency ablation versus reresection in treating recurrent hepatocellular carcinoma: a meta-analysis. Medicine (Baltimore) (2014) 0.75
The optimal follow-up period in patients with above 5-year disease-free survival after curative liver resection for hepatocellular carcinoma. J Korean Surg Soc (2013) 0.75
Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet (2012) 4.84
Alpha1,3-galactosyltransferase gene-knockout pigs for xenotransplantation: where do we go from here? Transplantation (2007) 3.65
Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res (2006) 2.86
Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am J Pathol (2004) 2.47
Procalcitonin as a predictive marker for surgical site infection in elective colorectal cancer surgery. Langenbecks Arch Surg (2013) 2.13
Deubiquitylation of histone H2A activates transcriptional initiation via trans-histone cross-talk with H3K4 di- and trimethylation. Genes Dev (2008) 1.87
Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages. Proc Natl Acad Sci U S A (2007) 1.80
Biliary complications after duct-to-duct biliary reconstruction in living-donor liver transplantation: causes and treatment. World J Surg (2007) 1.73
Adoptive immunotherapy with liver allograft-derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice. J Clin Invest (2009) 1.65
Blockade of invariant TCR-CD1d interaction specifically inhibits antibody production against blood group A carbohydrates. Blood (2013) 1.54
Treatment strategy for early hepatocellular carcinomas: comparison of radiofrequency ablation with or without transcatheter arterial chemoembolization and surgical resection. J Surg Oncol (2011) 1.54
Outcomes of living donor liver transplantation for hepatitis C virus-positive recipients in Japan: results of a nationwide survey. Transpl Int (2014) 1.49
Heme induces ubiquitination and degradation of the transcription factor Bach1. Mol Cell Biol (2007) 1.43
Using recipient's middle hepatic vein for drainage of the right paramedian sector in right liver graft. Transplantation (2008) 1.41
Glycogen synthase kinase 3 and h-prune regulate cell migration by modulating focal adhesions. Mol Cell Biol (2006) 1.41
Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection. Proc Natl Acad Sci U S A (2013) 1.40
Possible therapeutic effect of lipid supplementation on neurological complications in liver transplant recipients. Transpl Int (2007) 1.39
Augmentation of local antitumor immunity in liver by interleukin-2 gene transfer via portal vein. Cancer Gene Ther (2002) 1.38
Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers. Oncogene (2003) 1.38
Peritoneal cavity B cells are precursors of splenic IgM natural antibody-producing cells. J Immunol (2003) 1.34
Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans. Hepatology (2006) 1.28
Identification of 20 genes aberrantly methylated in human breast cancers. Int J Cancer (2005) 1.27
Haploinsufficiency of the Mus81-Eme1 endonuclease activates the intra-S-phase and G2/M checkpoints and promotes rereplication in human cells. Nucleic Acids Res (2006) 1.26
Thoracoscopic-assisted repair of a bochdalek hernia in an adult: a case report. J Med Case Rep (2010) 1.24
Laminin gamma2 mediates Wnt5a-induced invasion of gastric cancer cells. Gastroenterology (2009) 1.19
Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice. Hepatology (2004) 1.16
Retroperitoneal abscess complicated with necrotizing fasciitis of the thigh in a patient with sigmoid colon cancer. World J Surg Oncol (2009) 1.15
Primary lung cancer presenting with metastasis to the colon: a case report. World J Surg Oncol (2012) 1.15
Malignant peripheral nerve sheath tumor arising from the greater omentum: case report. World J Surg Oncol (2011) 1.13
Immunohistochemical and mutational analyses of Wnt signaling components and target genes in intrahepatic cholangiocarcinomas. Int J Oncol (2005) 1.11
Frequent alterations in the Wnt signaling pathway in colorectal cancer with microsatellite instability. Genes Chromosomes Cancer (2002) 1.09
Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal vein. J Surg Oncol (2002) 1.09
Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas. Int J Oncol (2004) 1.09
Antibody- and complement-independent phagocytotic and cytolytic activities of human macrophages toward porcine cells. Xenotransplantation (2005) 1.08
Desumoylation activity of Axam, a novel Axin-binding protein, is involved in downregulation of beta-catenin. Mol Cell Biol (2002) 1.08
Yeast glycogen synthase kinase-3 activates Msn2p-dependent transcription of stress responsive genes. Mol Biol Cell (2003) 1.07
XRCC3 deficiency results in a defect in recombination and increased endoreduplication in human cells. EMBO J (2004) 1.07
Liver sinusoidal endothelial cells tolerize T cells across MHC barriers in mice. J Immunol (2005) 1.04
Clinicopathologic features of poorly differentiated hepatocellular carcinoma. J Surg Oncol (2007) 1.03
CDX2 regulates multidrug resistance 1 gene expression in malignant intestinal epithelium. Cancer Res (2010) 1.02
Short disease-free interval is a significant risk factor for intrapulmonary recurrence after resection of pulmonary metastases in colorectal cancer. Colorectal Dis (2009) 1.01
Effect of aerobic exercise training on oxidative stress in patients with type 2 diabetes mellitus. Metabolism (2008) 1.01
Laparoscopic versus open surgery for colorectal cancer in elderly patients: a multicenter matched case-control study. Ann Surg Oncol (2014) 1.00
Immunological property of antibodies against N-glycolylneuraminic acid epitopes in cytidine monophospho-N-acetylneuraminic acid hydroxylase-deficient mice. J Immunol (2010) 0.99
High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer. Int J Cancer (2013) 0.99
NK cell tolerance in mixed allogeneic chimeras. J Immunol (2003) 0.98
Suppression of immune responses by nonimmunogenic oligodeoxynucleotides with high affinity for high-mobility group box proteins (HMGBs). Proc Natl Acad Sci U S A (2011) 0.98
Alterations and correlations of the components in the Wnt signaling pathway and its target genes in breast cancer. Oncol Rep (2005) 0.98
An anti-Wnt5a antibody suppresses metastasis of gastric cancer cells in vivo by inhibiting receptor-mediated endocytosis. Mol Cancer Ther (2011) 0.96
Atherosclerotic pseudoaneurysm of the left subclavian artery: a case report. Ann Thorac Cardiovasc Surg (2010) 0.95
Clinicopathologic features of hepatocellular carcinoma patients with compensated cirrhosis surviving more than 10 years after curative hepatectomy. World J Surg (2007) 0.94
Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma. Hepatogastroenterology (2005) 0.94
Typing of hepatic nonparenchymal cells using fibulin-2 and cytoglobin/STAP as liver fibrogenesis-related markers. Histochem Cell Biol (2004) 0.94
Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy. Transplantation (2006) 0.93
Interaction of POB1, a downstream molecule of small G protein Ral, with PAG2, a paxillin-binding protein, is involved in cell migration. J Biol Chem (2002) 0.93
Immunohistochemical and sequencing analyses of the Wnt signaling components in Japanese anaplastic thyroid cancers. Thyroid (2004) 0.93
Deficiency of N-glycolylneuraminic acid and Galα1-3Galβ1-4GlcNAc epitopes in xenogeneic cells attenuates cytotoxicity of human natural antibodies. Xenotransplantation (2010) 0.93
Hepatectomy for hepatocellular carcinoma in elderly patients aged 75 years or more. J Gastrointest Surg (2008) 0.92
Prognosis in patients with hepatocellular carcinoma correlates to mutations of p53 and/or hMSH2 genes. Eur J Cancer (2007) 0.92
Low incidence of acute rejection after living-donor liver transplantation: immunologic analyses by mixed lymphocyte reaction using a carboxyfluorescein diacetate succinimidyl ester labeling technique. Transplantation (2005) 0.92
Identification and characterization of a novel Dvl-binding protein that suppresses Wnt signalling pathway. Genes Cells (2003) 0.92
Splenectomy in chronic hepatic disorders: portal vein thrombosis and improvement of liver function. Dig Surg (2011) 0.92
JAMP, a Jun N-terminal kinase 1 (JNK1)-associated membrane protein, regulates duration of JNK activity. Mol Cell Biol (2005) 0.92